Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 75   

Articles published

ARNA 4.12 0.00 (0.00%)
price chart
Why Making Dramatic Moves : Barrick Gold (NYSE:ABX), Arena ...
On 1 Aug 2014 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) provided a corporate update and reported financial results for the second quarter ended June 30, 2014.
News Buzz: Netflix, Inc. (NASDAQ:NFLX), Arena Pharmaceuticals, Inc ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the second quarter ended June 30, 2014.
Stocks in the News - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Canadian ...  Techsonian (press release)
Related articles »  
Big Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals ...
Lakeway, NY - (MARKET NEWS CALL) - 8/29/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Notable Movers:Arena Pharmaceuticals, Inc. (ARNA), TriQuint Semiconductor ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) reported the gain of 0.71% and closed at $4.23with the total traded volume of 4.39 million shares.
What Do Today's Gains Represent For These Companies? Arena ...  NIS
Special News Alert: OncothyreonInc (USA) (NASDAQ:ONTY), Ariad ...  Market News Call
Related articles »  
Active Stocks to Watch: Arena Pharmaceuticals (NASDAQ:ARNA), Apple Inc ...
On August 01, 2014, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported financial results for the second quarter of its fiscal year 2014 (2QFY14).
What Should You Make Of These Falling Stocks? Arena Pharmaceuticals, Inc ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) lost four cents during yesterday's trading, a 0.91% decrease in value that left the stock at a closing price of $4.34.
Related articles »  
Small Cap Obesity Stock Orexigen Therapeutics (OREX) Awaits Its Fate (ARNA ...
Small cap biotech Orexigen Therapeutics, Inc (OREX) is developing an obesity drug with a FDA Prescription Drug User Fee Act (PDUFA) action date set for September 11 plus a look at the so-so performance of obesity stocks Arena Pharmaceuticals, Inc ...
Traders Are Watching: Epizyme, Inc. (NASDAQ:EPZM), Delta Air Lines Inc ...
The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14. On 28 August, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares fell -2.37% and was closed at $4.12. ARNA EPS growth in last ...
Related articles »  
Watch List - Arena Pharmaceuticals, Inc (NASDAQ:ARNA), Apptigo International ...
Las Vegas, NV - August- 04 2014 - (TechSonian) - Arena Pharmaceuticals, Inc (NASDAQ:ARNA) recently provided a corporate update and reported financial results for the second quarter ended June 30, 2014.
Arena Pharmaceuticals (ARNA) Releases Quarterly Earnings Results  WKRB News
Stocks In Focus: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), IAMGOLD Corp ...  Market News Call
Related articles »  
Watch List: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Alpha Natural ...
Lakeway, NY - (MARKET NEWS CALL) - 8/19/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »